Active Pharmaceutical Ingredient (API)
Vildagliptin
DPP-4 Inhibitor (Antidiabetic)
A drug for Type 2 Diabetes belonging to the DPP-4 inhibitor class. It works by inhibiting the enzyme Dipeptidyl Peptidase-4, which normally breaks down incretin hormones (like GLP-1). By preserving incretins, Vildagliptin enhances glucose-dependent insulin secretion and reduces glucagon levels.
Technical Profile
- Reference Code
- VIL123
- CAS Number
- 274901-16-5
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Vildagliptin as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| Galvus 50 OTC | Novartis India Ltd | Tablet (50 gm) | ₹285.00 | View Details |
| Vildagliptin 50 (Jan Aushadhi) OTC | Bureau of Pharma PSUs of India | Tablet (50 gm) | ₹65.00 | View Details |
| Jalra-M 50/500 OTC | USV Private Limited | Tablet (50 gm) | ₹180.00 | View Details |
| Vildagliptin 50 + Metformin 500 (Jan Aushadhi) OTC | Bureau of Pharma PSUs of India | Tablet (50 gm) | ₹45.00 | View Details |
| Galvus Met 50/850 OTC | Cipla Ltd | Tablet (50 gm) | ₹346.00 | View Details |
| Jalra-M 50/850 OTC | USV Private Limited | Tablet (50 gm) | ₹272.00 | View Details |
| Torglip M 50/850 OTC | Torrent Pharmaceuticals Ltd | Tablet (50 gm) | ₹105.00 | View Details |
| Vildagliptin 50 + Metformin 850 (Jan Aushadhi) OTC | Bureau of Pharma PSUs of India | Tablet (50 gm) | ₹52.50 | View Details |